STOCK TITAN

Cidara Therapeutics, Inc. (CDTX) Free Cash Flow by Year

CDTX

Cidara Therapeutics, Inc. recorded an outflow of $176.7M in free cash flow in fiscal year 2024. This represents a decrease of 670.2% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to an outflow of $132.9M in free cash flow. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters Cidara Therapeutics, Inc. has filed alongside them.

FY2024 annual
Free Cash Flow -$176.7M
YoY -670.2%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CDTX Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Free Cash Flow-$132.9M-$176.7M-670.2%-$22.9M+19.8%-$28.6M-13.1%-$25.3M+53.7%-$54.6M-91.1%-$28.6M+49.8%-$56.9M-13.3%-$50.2M-25.0%-$40.2M-48.1%-$27.1M-211.8%-$8.7MN/A

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

CDTX Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Free Cash Flow-$40.6M-10.4%-$41.0M+60.5%-$21.9M-229.2%-$29.4M-128.0%-$36.8M-1991.0%-$103.8M-3922.5%-$6.7M+39.3%-$12.9M+38.6%-$1.8M-106.3%$2.7M+122.9%-$11.0M+53.6%-$21.0M-40.9%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Cidara Therapeutics, Inc. financials

Frequently Asked Questions

What was Cidara Therapeutics, Inc.'s free cash flow in fiscal year 2024?

Cidara Therapeutics, Inc. recorded an outflow of $176.7M in free cash flow in fiscal year 2024.

How fast is Cidara Therapeutics, Inc.'s free cash flow growing?

Cidara Therapeutics, Inc. (CDTX) free cash flow fell by 670.2% year over year, from -$22.9M to -$176.7M in fiscal year 2024.

What is Cidara Therapeutics, Inc.'s free cash flow over the last twelve months?

Cidara Therapeutics, Inc. (CDTX) reported an outflow of $132.9M in free cash flow over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Cidara Therapeutics, Inc. (CDTX) reported -$40.6M in free cash flow in Q3 2025. This represents a decrease of 10.4% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Cidara Therapeutics, Inc. (CDTX) reported on that line in every period on record.